dibutyl phthalate has been researched along with benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)- in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishihara, A; Ishikawa, S; Ito, S; Mitobe, Y; Miyamoto, Y; Mizutani, T; Nagase, T; Sato, N; Sekino, E; Takenaga, N; Tanaka, T; Tokita, S; Yoshimoto, R | 1 |
Fettes, A; Freichel, C; Gatti-McArthur, S; Hertel, C; Huwyler, J; Mohr, P; Nakagawa, T; Nettekoven, M; Pierson, PD; Plancher, JM; Raab, S; Richter, H; Roche, O; RodrÃguez Sarmiento, RM; Schmitt, M; Schuler, F; Takahashi, T; Taylor, S; Ullmer, C; Wiegand, R | 1 |
Berlin, M; Boyce, CW; Ruiz, Mde L | 1 |
Czechtizky, W; Francon, D; Gao, Z; George, PG; Griebel, G; Hendrix, JA; Hurst, WJ; Nagorny, R; Pichat, P; Schwink, L; Stengelin, S | 1 |
1 review(s) available for dibutyl phthalate and benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)-
Article | Year |
---|---|
Histamine H3 receptor as a drug discovery target.
Topics: Animals; Drug Discovery; Drug Industry; Drug Inverse Agonism; Histamine Agonists; Histamine Antagonists; Humans; Ligands; Private Sector; Receptors, Histamine H3 | 2011 |
3 other study(ies) available for dibutyl phthalate and benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)-
Article | Year |
---|---|
Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.
Topics: Animals; Blood-Brain Barrier; Brain; Histamine; Histamine Agonists; Humans; Molecular Structure; Quinazolinones | 2008 |
5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.
Topics: Amides; Animals; Cell Membrane Permeability; Computational Biology; Drug Design; Histamine Agonists; Hydrophobic and Hydrophilic Interactions; Indoles; Obesity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Structure-Activity Relationship | 2009 |
Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.
Topics: Administration, Oral; Animals; Dogs; Drug Stability; Guinea Pigs; Haplorhini; Histamine H3 Antagonists; Humans; Male; Mice; Pyrans; Pyrrolidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3; Sheep; Sleep Disorders, Circadian Rhythm; Substrate Specificity | 2013 |